Asia-Pacific: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Asia-Pacific

The Asia-Pacific medicaments containing hormones market rose sharply to $X in 2022, with an increase of X% against the previous year. Overall, consumption saw a buoyant increase. Over the period under review, the market attained the peak level at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Medicaments Containing Hormones Production in Asia-Pacific

In value terms, medicaments containing hormones production expanded remarkably to $X in 2022 estimated in export price. Overall, production showed a strong expansion. The most prominent rate of growth was recorded in 2019 with an increase of X%. The level of production peaked at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Medicaments Containing Hormones Exports

Exports in Asia-Pacific

In 2022, shipments abroad of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the third year in a row after seven years of decline. In general, exports, however, continue to indicate a abrupt decline. Over the period under review, the exports reached the maximum at X tons in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

In value terms, medicaments containing hormones exports shrank slightly to $X in 2022. Over the period under review, exports, however, showed a abrupt downturn. The most prominent rate of growth was recorded in 2016 with an increase of X%. As a result, the exports reached the peak of $X. From 2017 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

In 2022, Pakistan (X tons) was the major exporter of medicaments containing hormones but not antibiotics, constituting X% of total exports. It was distantly followed by Indonesia (X tons), mixing up a X% share of total exports. India (X tons) held a relatively small share of total exports.

From 2012 to 2022, the biggest increases were recorded for Indonesia (with a CAGR of X%), while shipments for the other leaders experienced mixed trends in the exports figures.

In value terms, the largest medicaments containing hormones supplying countries in Asia-Pacific were Indonesia ($X), Pakistan ($X) and India ($X), with a combined X% share of total exports.

Indonesia, with a CAGR of X%, saw the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced a decline in the exports figures.

Export Prices by Country

The export price in Asia-Pacific stood at $X per ton in 2022, dropping by X% against the previous year. Over the period under review, the export price showed a mild reduction. The pace of growth appeared the most rapid in 2013 an increase of X%. Over the period under review, the export prices attained the peak figure at $X per ton in 2017; however, from 2018 to 2022, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was India ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (X%), while the other leaders experienced a decline in the export price figures.

Medicaments Containing Hormones Imports

Imports in Asia-Pacific

Medicaments containing hormones imports rose sharply to X tons in 2022, increasing by X% compared with 2021 figures. In general, imports, however, continue to indicate a deep reduction. The pace of growth was the most pronounced in 2016 when imports increased by X% against the previous year. As a result, imports attained the peak of X tons. From 2017 to 2022, the growth of imports remained at a lower figure.

In value terms, medicaments containing hormones imports skyrocketed to $X in 2022. Over the period under review, imports recorded a relatively flat trend pattern. Over the period under review, imports reached the maximum at $X in 2014; however, from 2015 to 2022, imports remained at a lower figure.

Imports by Country

Afghanistan represented the largest importing country with an import of about X tons, which accounted for X% of total imports. Malaysia (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by India (X%), Myanmar (X%), Pakistan (X%) and Japan (X%). Singapore (X tons) took a relatively small share of total imports.

Imports into Afghanistan decreased at an average annual rate of X% from 2012 to 2022. At the same time, India (X%), Singapore (X%), Myanmar (X%) and Pakistan (X%) displayed positive paces of growth. Moreover, India emerged as the fastest-growing importer imported in Asia-Pacific, with a CAGR of X% from 2012-2022. By contrast, Malaysia (X%) and Japan (X%) illustrated a downward trend over the same period. While the share of India (X p.p.), Myanmar (X p.p.), Pakistan (X p.p.), Malaysia (X p.p.), Singapore (X p.p.) and Japan (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, India ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in Asia-Pacific, comprising X% of total imports. The second position in the ranking was held by Japan ($X), with a X% share of total imports. It was followed by Afghanistan, with a X% share.

In India, medicaments containing hormones imports increased at an average annual rate of X% over the period from 2012-2022. The remaining importing countries recorded the following average annual rates of imports growth: Japan (X% per year) and Afghanistan (X% per year).

Import Prices by Country

The import price in Asia-Pacific stood at $X per ton in 2022, picking up by X% against the previous year. Overall, the import price saw resilient growth. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was India ($X per ton), while Myanmar ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Myanmar (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :